España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bicycle Therapeutics
BCYC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.68
-0.32
-2.13%
At close: -
$14.68
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Bicycle Therapeutics (BCYC) Forecast
News
Earnings
Bicycle Therapeutics (BCYC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Bicycle Therapeutics (NASDAQ:BCYC) Stock
Bicycle Therapeutics Stock (NASDAQ: BCYC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Monday, December 16, 2024
Breaking Down Bicycle Therapeutics: 8 Analysts Share Their Views
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Bicycle ...
Benzinga Newsdesk
Friday, December 13, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
B. Riley Securities Maintains Neutral on Bicy...
Benzinga Newsdesk
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
Vandana Singh
Reported Earlier, Bicycle Therapeutics Unveil...
Benzinga Newsdesk
Monday, November 25, 2024
Bicycle Therapeutics Plans To Present Data At...
Benzinga Newsdesk
Friday, November 08, 2024
Stephens & Co. Initiates Coverage On Bicycle ...
Benzinga Newsdesk
Friday, November 01, 2024
RBC Capital Reiterates Outperform on Bicycle ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Bicycle...
Benzinga Newsdesk
Thursday, October 31, 2024
Needham Reiterates Buy on Bicycle Therapeutic...
Benzinga Newsdesk
Thursday, October 24, 2024
Navigating 11 Analyst Ratings For Bicycle Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Bicycle...
Benzinga Newsdesk
Needham Reiterates Buy on Bicycle Therapeutic...
Benzinga Newsdesk
Wednesday, October 23, 2024
Bicycle Therapeutics Announced The Presentati...
Benzinga Newsdesk
Monday, September 16, 2024
Bicycle Therapeutics shares are trading lower...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Bicycle...
Benzinga Newsdesk
Needham Reiterates Buy on Bicycle Therapeutic...
Benzinga Newsdesk
Reported Saturday, Bicycle Therapeutics Annou...
Benzinga Newsdesk
Monday, September 09, 2024
Bicycle Therapeutics shares are trading highe...
Benzinga Newsdesk
Needham Reiterates Buy on Bicycle Therapeutic...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Bi...
Benzinga Newsdesk
Friday, September 06, 2024
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone
Vandana Singh
In-Depth Examination Of 5 Analyst Recommendations For Bicycle Therapeutics
Benzinga Insights
RBC Capital Initiates Coverage On Bicycle The...
Benzinga Newsdesk
Wednesday, August 07, 2024
The Latest Analyst Ratings For Bicycle Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Bicycle...
Benzinga Newsdesk
Bicycle Therapeutics shares are trading lower...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Bicycle T...
Benzinga Newsdesk
5Needham Reiterates Buy on Bicycle Therapeuti...
Benzinga Newsdesk
B. Riley Securities Downgrades Bicycle Therap...
Benzinga Newsdesk
Tuesday, August 06, 2024
Bicycle Therapeutics Q2 2024 GAAP EPS $(0.77)...
Benzinga Newsdesk
Tuesday, June 18, 2024
Bicycle Therapeutics Filed A Prospectus Suppl...
Benzinga Newsdesk
Thursday, May 23, 2024
Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views
Avi Kapoor
Gold Falls Sharply; US Composite PMI Surges In May
Avi Kapoor
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Bicycle Therapeutics shares are trading highe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Bicycle Therapeutics Reports $555M Private Pl...
Benzinga Newsdesk
Friday, May 03, 2024
HC Wainwright & Co. Reiterates Buy on Bicycle...
Benzinga Newsdesk
Thursday, May 02, 2024
Bicycle Therapeutics' Cash And Cash Equivalen...
Benzinga Newsdesk
Bicycle Therapeutics Q1 2024 GAAP EPS $(0.62)...
Benzinga Newsdesk
Wednesday, April 10, 2024
Expert Ratings For Bicycle Therapeutics
Benzinga Insights
Needham Reiterates Buy on Bicycle Therapeutic...
Benzinga Newsdesk
Wednesday, February 21, 2024
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Canaccord Genuity Reiterates Buy on Bicycle T...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch